Pemphigus foliaceus. Case presentation
Abstract
Pemphigus foliaceus is included within the bullosous diseases, considered a chronic and relatively benign variety of pemphigus, where the general state of the patient is affected very little. It is considered that it is an autoinmune disease of unknown etiology, that is characterized to show deposits of self-antibodies: Inmunoglobulins and complements in the intercellular unions. A case of pemphigus foliaceus in an adolescent of 17 years with antecedents of Bronchial Asthma is presented. The routine studies included physical examination, complementary examinations of hemochemestry, inmunology, micology and skin's biopsy.Downloads
References
2. Giraldo N, Escobar C. Enfermedades vésico-ampollosas. En: Falabella R, Escobar C, Giraldo N. Dermatología. 5ta ed. Bogotá: Corporación para Investigaciones Biológicas; 1997. pp. 401 -13.
3. Stanley JR. Pemphigus. En: Freedberg IM, Eisen AZ, Austen KF, Goldsmth LA, Katz SI. Fitzpatricks A. Dermatology in general medicine. 6ta ed. v.1. New York: Mc Graw-Hill; 2003. p. 558-67.
4. Guillén C, Botella R, Sanmartín D. Manual Janssen de enfermades de la piel. 1ra. ed. Barcelona: Masson; 1996.
5. Rook A, Wilkinson DS, Ebling F JG. Tratado de dermatología. 4ta ed. Barcelona: Doyma; 1989.
6. Daht MV. Clinical Inmunodermatology. Chicago. Year Book Medical Publishers; 1981.
7. Mc Kee P. Pathology of the skin. London: Gower Medical Publishing;1990.
8. Mascaro JM, Giudice GJ, Dìaz LA. Desmosomas y Hemidesmosomas. Med Cut 1994: XXII: 193-205.
9. Balding SD, Prost C, Díaz B. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP 180 extracellular domain. J Invest Dermatol 1996; 106: 141-146.
10. Basset N. Dapsone in initial treatement of superficial pemphigus. Arch dermatol 1987; 123:783.
Downloads
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
